Suter-Dick, LauraMitchell, Isabelle2021-05-102021-05-102020-10-282673-24240009-429310.2533/chimia.2020.765https://irf.fhnw.ch/handle/11654/32426For over 50 years, Switzerland has been one of the leading countries driving innovation in biotechnology and its industrial applications. Today, some 1,000 biotech companies form a tightly knit, cross-functional network ranging from research through to manufacturing. This network comprises R&D companies, contract research organizations, and highly specialized advisors and biotech investors. Together, they form an external innovation pool that complements the in-house R&D capacity of the large multi-national pharma companies. A highly effective startup framework, solid acceleration mechanisms, and innovative investors enable the emergence of a continuous flow of biotech startups that revitalize the industry with new technologies and products supporting drug development and diagnostics.en01A - Beitrag in wissenschaftlicher Zeitschrift765-767